Page last updated: 2024-10-28

haloperidol and Cavernous Angioma, Central Nervous System

haloperidol has been researched along with Cavernous Angioma, Central Nervous System in 3 studies

Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Engin, EF1
Polat, B1
Ertan Akan, G1
Akgül, E1
Espinoza López, DA1
Serrano Rubio, AA1
Perdomo Pantoja, A1
Marchione, P1
Vento, C1
Marianetti, M1
Romeo, T1
Amabile, GA1
Giacomini, P1

Other Studies

3 other studies available for haloperidol and Cavernous Angioma, Central Nervous System

ArticleYear
Cerebral proliferative angiopathy accompanied by cerebral cavernous malformation: A case report.
    Clinical neurology and neurosurgery, 2021, Volume: 210

    Topics: Adult; Anticonvulsants; Antipsychotic Agents; Cerebral Small Vessel Diseases; Gabapentin; Haloperido

2021
Cerebral cavernous malformation in a woman presenting with hemichorea: Response to haloperidol.
    Neurologia (Barcelona, Spain), 2017, Volume: 32, Issue:8

    Topics: Anti-Dyskinesia Agents; Brain; Central Nervous System Neoplasms; Chorea; Female; Haloperidol; Hemang

2017
Hemiballismus in subthalamic haemorrhage: efficacy of levetiracetam.
    European journal of neurology, 2009, Volume: 16, Issue:6

    Topics: Aged; Anti-Dyskinesia Agents; Anticonvulsants; Antihypertensive Agents; Ataxia; Cerebellum; Dose-Res

2009